Indicator Details: Association Between Timing of Pre-ESRD Care and First-year Mortalitya,b,c
Data Sources
 
Stratification and Year Choices:

  Source
  • CMS-ESRD

  View Data By:
  Chart Format


Published literature or one-time analysis, ongoing surveillance not available Published literature or one-time analysis, ongoing surveillance not available

+ View Data Table

Footnotes:
a Relative mortality risk for each type of pre-ESRD care is adjusted for the other two types of care.

b All durations of Nephrology Care (except 'Unknown') are significant at the P<0.05 level as compared to 'No Care'.

c Adapted from Saran et al. (2007).




Longer duration of nephrology care prior to ESRD onset was associated with significantly better survival.
Chart Explanation: When compared to patients that did not received pre-ESRD nephrology care, patients who saw a nephrologist prior to ESRD had significantly better survival than those who did not, with the best survival among those with more than 1 year of care. Patients with 0-6, 6-12, and 12+ months of care had 19%, 17%, and 29% lower mortality respectively. Patients with >6 months of pre-ESRD dietitian care had better survival than those who did not, but these effects were not statistically significant (P=0.11 and 0.14 for 6-12 and 12+ months respectively). There was no association between pre-ESRD EPO treatment and mortality. Compared to patients with documented pre-ESRD care, patients that had undocumented care had higher mortality. The difference was statistically significant compared to those with any pre-ESRD nephrology care, those with 6-12 months of dietitian care, and those with 6-12 months of EPO treatment. Results were similar when excluding adjustments for eGFR, hemoglobin, and albumin values.
Within the United States, health insurance for all individuals with end-stage renal disease (ESRD) is covered by the Centers for Medicare and Medicaid Services. These results were taken from analyses using 100% of the national ESRD population data (Saran R, et al. Earlier pre-ESRD care throughout the United States is associated with better survival for dialysis patients in their first year of ESRD. J Am Soc Nephrol 18: 299A, 2007).

Beginning in June 2005, information related to pre-ESRD care was collected on all new ESRD patients via the Medical Evidence Form (CMS-2728). In November 2007, researchers presented “Earlier Pre-ESRD Care Throughout the U.S. is Associated with Better Survival for Dialysis Patients in Their First Year of ESRD” (Saran et al., 2007) at the 2007 annual meeting of the American Society of Nephrology. Utilizing national CMS data and data collected on the form CMS-2728 for 52,277 incident ESRD patients between June 1, 2005 and December 31, 2005 who survived to day 90 of ESRD treatment, timing of pre-ESRD nephrology care, dietitian care and EPO treatment were investigated. A patient was considered under the care of a nephrologist, kidney dietitian, or EPO treated if their form indicated “Yes” in the check box for the corresponding question; if the box “No” was checked, the patient was classified as none; if the box “Unknown” was checked, the patient was classified as unknown. Timing of pre-ESRD care was assigned according to the check box on the form indicating “6-12 months,” “>12 months,” or assigned “<6 months” if the form indicated treatment but the length of treatment box was left unchecked.
FieldData
Description of MeasurePre-ESRD care
Data SourceCenters for Medicare and Medicaid Services Medical Evidence Form (CMS-2728)
Type of Data SourceAdministrative
Data SetCMS
Health Care System DataNo
Regional or National?National
Demographic GroupIncident dialysis patients
NumeratorAll individuals in denominator
Denominator52,277 ESRD patients incident between 6/1/05 and 12/31/05 who survived to day 90 of ESRD treatment
Definition of diagnosed CKDStage 5 with Medicare-eligibility for ESRD treatment
Primary Data Source IndicatorNephrology care, Dietitian care and Erythropoietin (EPO) treatment immediately prior to ESRD
Primary Indicator Method of MeasurementReported on CMS-2728 form
Secondary (1) VariableDemographics (e.g. age, gender, race/ethnicity), Health (e.g. BMI, diabetes status, dialysis modality), Labs (e.g. serum creatinine, urine albumin, hemoglobin)
Secondary (1) Indicator Method of MeasurementAll as reported on CMS 2728 form
Secondary (2) VariableeGFR
Secondary (2) Indicator Method of MeasurementCalculated using 4-variable, MDRD-study formula using data from CMS 2728 form
Secondary (4) VariableMortality
Secondary (4) Indicator Method of MeasurementMultiple sources: CROWNWeb (Consolidated Renal Operations in a Web-enabled format) Form 2746, Renal Management Information System (REMIS), ESRD Death Notification
Frequency of Measurement (Primary)Once
Period Currently Available2005
Additional Data Items of InterestTracking of care immediately prior to ESRD registration began in 2005.
Limitations of IndicatorInformation on pre-ESRD care is self-reported. Some 10-18% of individuals were unsure of their pre-ESRD care level.
References and Sources:
  • Saran R, Shearon T, Shahinian V, et al. Earlier pre-ESRD care throughout the U.S is associated with better survival for dialysis patients in their first year of ESRD. [Abstract F-PO893] J. Am. Soc. Nephrol. 2007; 18:299A.
Suggested Citation:
Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System—United States.
website. http://www.cdc.gov/ckd